{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:47:50Z","timestamp":1780390070843,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Beijing Institute of Pharmacology and Toxicology"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.lfs.2019.117033","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T11:23:48Z","timestamp":1572866628000},"page":"117033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Flumazenil-insensitive benzodiazepine binding sites in GABAA receptors contribute to benzodiazepine-induced immobility in zebrafish larvae"],"prefix":"10.1016","volume":"239","author":[{"given":"Yanqing","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2019.117033_bib1","doi-asserted-by":"crossref","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","article-title":"Structure, function, and modulation of GABAA receptors","volume":"287","author":"Sigel","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2019.117033_bib2","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.febslet.2006.02.002","article-title":"A GABAA receptor of defined subunit composition and positioning: concatenation of five subunits","volume":"580","author":"Baur","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2019.117033_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/bs.apha.2014.10.001","article-title":"Behavioral functions of GABAA receptor subtypes--the Zurich experience","volume":"72","author":"Crestani","year":"2015","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.lfs.2019.117033_bib4","doi-asserted-by":"crossref","first-page":"12757","DOI":"10.1523\/JNEUROSCI.3340-09.2009","article-title":"Extrasynaptic GABAA receptors: form, pharmacology, and function","volume":"29","author":"Belelli","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2019.117033_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.apha.2014.10.002","article-title":"Allosteric modulation of GABAA receptors via multiple drug-binding sites","volume":"72","author":"Sieghart","year":"2015","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.lfs.2019.117033_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuropharm.2018.01.036","article-title":"GABAA receptor: positive and negative allosteric modulators","volume":"136","author":"Olsen","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2019.117033_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.300.1.2","article-title":"A new benzodiazepine pharmacology","volume":"300","author":"Mohler","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2019.117033_bib8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2019.117033_bib9","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/81800","article-title":"Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms","volume":"3","author":"Walters","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.lfs.2019.117033_bib10","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1213\/ANE.0b013e3181f9c035","article-title":"Diazepam decreases action potential firing of neocortical neurons via two distinct mechanisms","volume":"111","author":"Drexler","year":"2010","journal-title":"Anesth. Analg."},{"issue":"10","key":"10.1016\/j.lfs.2019.117033_bib11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrd4627","article-title":"Zebrafish as tools for drug discovery","volume":"14","author":"MacRae","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"13","key":"10.1016\/j.lfs.2019.117033_bib12","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1111\/bph.13754","article-title":"Zebrafish models in neuropsychopharmacology and CNS drug discovery","volume":"174","author":"Khan","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2019.117033_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/ALN.0000000000002281","article-title":"High-throughput screening in larval zebrafish identifies novel potent sedative-hypnotics","volume":"129","author":"Yang","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.lfs.2019.117033_bib14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.neuroscience.2016.07.018","article-title":"Characterization of the gamma-aminobutyric acid signaling system in the zebrafish (Danio rerio Hamilton) central nervous system by reverse transcription-quantitative polymerase chain reaction","volume":"343","author":"Cocco","year":"2017","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.lfs.2019.117033_bib15","doi-asserted-by":"crossref","first-page":"e0196083","DOI":"10.1371\/journal.pone.0196083","article-title":"Expression of the eight GABAA receptor alpha subunits in the developing zebrafish central nervous system","volume":"13","author":"Monesson-Olson","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2019.117033_bib16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/bs.irn.2016.02.016","article-title":"The zebrafish, a novel model organism for screening compounds affecting acute and chronic ethanol-induced effects","volume":"126","author":"Tran","year":"2016","journal-title":"Int. Rev. Neurobiol."},{"issue":"6","key":"10.1016\/j.lfs.2019.117033_bib17","first-page":"1061","article-title":"A reappraisal of its pharmacological properties and therapeutic efficacy as a benzodiazepine antagonist","volume":"42","author":"Flumazenil","year":"1991","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.lfs.2019.117033_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0404.2008.01004.x","article-title":"Benzodiazepines in epilepsy: pharmacology and pharmacokinetics","volume":"118","author":"Riss","year":"2008","journal-title":"Acta Neurol. Scand."},{"issue":"6","key":"10.1016\/j.lfs.2019.117033_bib19","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s11064-014-1243-0","article-title":"Alcohol selectivity of \u03b23-containing GABAA receptors: evidence for a unique extracellular alcohol\/imidazobenzodiazepine Ro15-4513 binding site at the \u03b1+\u03b2- subunit interface in \u03b1\u03b23\u03b4 GABAA receptors","volume":"39","author":"Wallner","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2019.117033_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pbb.2009.07.009","article-title":"Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety","volume":"94","author":"Bencan","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.lfs.2019.117033_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbr.2011.05.034","article-title":"Antipsychotic drugs reverse MK-801-induced cognitive and social interaction deficits in zebrafish (Danio rerio)","volume":"224","author":"Seibt","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.lfs.2019.117033_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/rns.2011.005","article-title":"Sleep and its regulation in zebrafish","volume":"22","author":"Zhdanova","year":"2011","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.lfs.2019.117033_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbr.2011.03.025","article-title":"Patterns of avoidance behaviours in the light\/dark preference test in young juvenile zebrafish: a pharmacological study","volume":"222","author":"Steenbergen","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.lfs.2019.117033_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00175201","article-title":"Chronic treatment with Ro 15-1788 distinguishes between its benzodiazepine antagonist, agonist and inverse agonist properties","volume":"89","author":"File","year":"1986","journal-title":"Psychopharmacol. (Berl.)"},{"issue":"3","key":"10.1016\/j.lfs.2019.117033_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00213-003-1583-y","article-title":"Behavioral effects of flumazenil in the social conflict test in mice","volume":"171","author":"Uhlirova","year":"2004","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.lfs.2019.117033_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.vascn.2017.07.002","article-title":"Measuring drug absorption improves interpretation of behavioral responses in a larval zebrafish locomotor assay for predicting seizure liability","volume":"88","author":"Cassar","year":"2017","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"2","key":"10.1016\/j.lfs.2019.117033_bib27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1476-5381.2011.01779.x","article-title":"A novel GABAA receptor pharmacology: drugs interacting with the alpha(+) beta(-) interface","volume":"166","author":"Sieghart","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2019.117033_bib28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor alpha1 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.lfs.2019.117033_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pnpbp.2016.12.004","article-title":"Time-dependent interacting effects of caffeine, diazepam, and ethanol on zebrafish behaviour","volume":"75","author":"Tran","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatr."},{"issue":"3","key":"10.1016\/j.lfs.2019.117033_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0735-6757(98)90091-2","article-title":"Continuous flumazenil infusion in preventing complications arising from severe benzodiazepine intoxication","volume":"16","author":"Chern","year":"1998","journal-title":"Am. J. Emerg. Med."},{"issue":"2","key":"10.1016\/j.lfs.2019.117033_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1081\/CLT-120030946","article-title":"Flumazenil--treatment or toxin","volume":"42","author":"Seger","year":"2004","journal-title":"J. Toxicol. Clin. Toxicol."},{"issue":"4","key":"10.1016\/j.lfs.2019.117033_bib32","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1476-5381.2011.01615.x","article-title":"Flavan-3-ol esters: new agents for exploring modulatory sites on GABAA receptors","volume":"165","author":"Fernandez","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2019.117033_bib33","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1111\/j.1471-4159.2008.05574.x","article-title":"Covalent modification of GABAA receptor isoforms by a diazepam analogue provides evidence for a novel benzodiazepine binding site that prevents modulation by these drugs","volume":"106","author":"Baur","year":"2008","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.lfs.2019.117033_bib34","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.bjp.0704795","article-title":"Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABAA receptors","volume":"136","author":"Brown","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2019.117033_bib35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuropharm.2016.01.003","article-title":"Functional sites involved in modulation of the GABAA receptor channel by the intravenous anesthetics propofol, etomidate and pentobarbital","volume":"105","author":"Maldifassi","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2019.117033_bib36","doi-asserted-by":"crossref","first-page":"25943","DOI":"10.1038\/srep25943","article-title":"Novel positive allosteric modulators of GABAA receptors with anesthetic activity","volume":"6","author":"Maldifassi","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519309609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519309609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:31:54Z","timestamp":1758400314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519309609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":36,"alternative-id":["S0024320519309609"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117033","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flumazenil-insensitive benzodiazepine binding sites in GABAA receptors contribute to benzodiazepine-induced immobility in zebrafish larvae","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117033"}}